Jen Johannesen

AtomVie Global Radiopharma Inc. joins the CNIC to bring new leadership, innovation, and collaboration to the radiopharmaceutical industry.

Toronto – November 2, 2022 – AtomVie Global Radiopharma Inc. (AtomVie), a manufacturer and supplier of multiple finished-dose therapeutic radiopharmaceutical products, is the newest member of the Canadian Nuclear Isotope Council (CNIC). AtomVie has developed over 7 years of experience in the GMP manufacturing and global distribution of radiopharmaceuticals as the former CMO business unit … Read more

Isotope Production System at Bruce Power commences Commercial Production of Lutetium-177

Toronto, Ontario – October 25, 2022 – Yesterday, the international partnership between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich (ITM), announced the start of commercial production of lutetium-177. Lutetium-177 is a medical isotope used for targeted cancer therapies. The properties of the isotope allow it to bond with a … Read more

Nuclear Science Week 2022: Canadian Isotopes are Transforming Healthcare

The week October 17th-21st, 2022 marked this year’s Nuclear Science Week (NSW), an international week-long celebration of all aspects of nuclear science. Held each October since 2010, NSW provides the opportunity to highlight innovation in nuclear and recognize the vital role it plays in the lives of people around the world. During NSW, many activities … Read more

CNIC Member Profile: Promation

Started in 1995, Promation quickly became an industry leader in automotive automation. Soon after, Promation leveraged its automation know-how and expanded into automation and tooling for nuclear applications for reactor maintenance, inspection, and refurbishment. Recently, Promation applied their knowledge of nuclear and automation to branch into the radiopharmaceutical industry. Promation now uses automation to developing … Read more

BWXT Medical Submits Tc-99m Generator New Drug Application to FDA

Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its technetium-99m (Tc-99m) generator for … Read more

The CNIC joins twenty leading organizations as part of a joint Industry Statement touting the benefits of nuclear isotopes.

Toronto – August 16, 2022 – The Canadian Nuclear Isotope Council (CNIC) is proud to participate in a joint Industry Statement to the Tenth Review Conference of the Parties to the Treaty on the Non-Proliferation of Nuclear Weapons (NPT) alongside international and national industry associations covering a wide variety of nuclear applications. The NPT importantly … Read more

BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products

(OTTAWA, ON – June 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and services agreement that strengthens their existing partnership for the production of medical isotopes. This agreement will enable BWXT Medical to manufacture high purity Actinium-225 (Ac-225) … Read more

Job Posting: Policy, Government and Stakeholder Relations Specialist (Hybrid) – CLOSED

THIS POSITION IS NOW FILLED Job Overview Policy, Government and Stakeholder Relations Specialist at the CNIC is responsible for connecting federal, provincial, and municipal political leaders to the organization and the broader Canadian Isotope Ecosystem. Reporting to the Executive Director, this position is responsible for public outreach, engagement, and education efforts. The specialist will also … Read more

Laurentis is helping meet global demands by increasing He-3 production

Helium-3 (He-3) is a rare isotope used in research, border security and medical imaging In a world where raw materials and supplies are under tension, Helium-3 (He-3), a rare isotope used in quantum computing, neutron research, border security and medical imaging, is no exception. Laurentis Energy Partners is responding by stepping up its He-3 production … Read more

Installation complete of new Isotope Production System at Bruce Power, paving way for production of life-saving medical isotopes

TIVERTON, ON – January 24, 2022 – Bruce Power and Isogen (a partnership between Kinectrics and Framatome) have completed the installation of a groundbreaking Isotope Production System (IPS), making Unit 7 the first power reactor in the world with installed capability to produce Lutetium-177 (Lu-177). Lu-177 is a medical isotope used in the treatment of … Read more